TR202013390A2 - Bir seramidaz inhibitörü olan B13 ve nano formunun, akciğer kanseri hücrelerinde terapötik kullanımı - Google Patents

Bir seramidaz inhibitörü olan B13 ve nano formunun, akciğer kanseri hücrelerinde terapötik kullanımı

Info

Publication number
TR202013390A2
TR202013390A2 TR2020/13390A TR202013390A TR202013390A2 TR 202013390 A2 TR202013390 A2 TR 202013390A2 TR 2020/13390 A TR2020/13390 A TR 2020/13390A TR 202013390 A TR202013390 A TR 202013390A TR 202013390 A2 TR202013390 A2 TR 202013390A2
Authority
TR
Turkey
Prior art keywords
lung cancer
nanoform
cancer cells
therapeutic use
nanoparticles
Prior art date
Application number
TR2020/13390A
Other languages
English (en)
Inventor
Vejselova Sezer Canan
Mehtap Kutlu Hati̇ce
Original Assignee
Eskisehir Teknik Ueniversitesi Idari Ve Mali Isler Daire Baskanligi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eskisehir Teknik Ueniversitesi Idari Ve Mali Isler Daire Baskanligi filed Critical Eskisehir Teknik Ueniversitesi Idari Ve Mali Isler Daire Baskanligi
Priority to PCT/TR2020/051328 priority Critical patent/WO2021133335A1/en
Publication of TR202013390A2 publication Critical patent/TR202013390A2/tr

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Buluş, B13 yüklenmiş katı lipid nanopartiküllerin sentezlenmesi, bu nanopartiküllerin ve B13' ün hem insan akciğer kanseri (A549) hem de sağlıklı akciğer (Beas-2B) hücre hatları üzerinde tedavi etkinliklerinin, sitotoksik, ince yapısal ve morfolojik değişikliklerinin belirlenmesi ve B13 yüklenmiş katı lipid nanopartiküllerin akciğer kanseri tedavisindeki kullanımı ilgidir.
TR2020/13390A 2019-12-26 2020-08-25 Bir seramidaz inhibitörü olan B13 ve nano formunun, akciğer kanseri hücrelerinde terapötik kullanımı TR202013390A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/TR2020/051328 WO2021133335A1 (en) 2019-12-26 2020-12-18 Therapeutic use of a ceramidase inhibitor b13 and its nano form in lung cancer cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR201921845 2019-12-26

Publications (1)

Publication Number Publication Date
TR202013390A2 true TR202013390A2 (tr) 2021-07-26

Family

ID=83366596

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2020/13390A TR202013390A2 (tr) 2019-12-26 2020-08-25 Bir seramidaz inhibitörü olan B13 ve nano formunun, akciğer kanseri hücrelerinde terapötik kullanımı

Country Status (1)

Country Link
TR (1) TR202013390A2 (tr)

Similar Documents

Publication Publication Date Title
MX2016010683A (es) Terapia para tratar enfermedades mediante la induccion de respuesta inmune de las células que expresan trop-2.
EP2597464A3 (en) Metabolomic profiling of prostate cancer
EP3885366A3 (en) Therapeutic antibodies against ror-1 protein and methods for use of same
EP1872124A4 (en) DIAGNOSTIC MARKERS FOR THE TREATMENT AND EVOLUTION OF BREAST CANCER AND METHODS OF USE
BR112013004914A2 (pt) "composições de pele e métodos de uso das mesmas".
BR112014014781A8 (pt) sistema para imagear lesões alinhando superfícies de tecido
TR201807411T4 (tr) DNA-PK inhibitörleri.
WO2015017607A3 (en) METHODS OF TREATING VARIOUS CANCERS USING AN AXL/cMET INHIBITOR ALONE OR IN COMBINATION WITH OTHER AGENTS
NZ596490A (en) Monoclonal antibodies that bind GT468 for the treatment of cancer
EP3755321A4 (en) CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR THE TARGETING OF PROSTATE CANCER
MX2012000285A (es) Nanoparticulas metalicas, preparacion y uso de las mismas.
MA38318A1 (fr) Compositions de nanoparticules inorganiques combinées à des rayonnements ionisants pour le traitement du cancer
WO2006027693A3 (en) Tumor specific genes and variant RNAS and uses thereof as targets for cancer therapy and diagnosis
NZ603952A (en) Phosphaplatins and their use for treatment of cancers
DOP2009000208A (es) Métodos de tratamiento del cáncer mediante administración de combinaciones de il-18 humana
MA33091B1 (fr) Combinaisons pharmaceutiques comprenant rdea119/bay 869766 pour le traitement de cancers specifiques
MX2019009798A (es) Tratamiento de la hidradenitis supurativa.
RS63918B1 (sr) Antitelo-lek konjugati i njihova upotreba u tretmanu kancera
TR202013390A2 (tr) Bir seramidaz inhibitörü olan B13 ve nano formunun, akciğer kanseri hücrelerinde terapötik kullanımı
DE602005027739D1 (de) Arylsubstituiertes benzimidazol- und imidazopyridinether als wirkstoffe gegen krebs
WO2015148971A3 (en) Method for detecting or treating triple negative breast cancer
WO2009067520A3 (en) Peptides specific for hepatocellular carcinoma cells and applications thereof
HRP20090355B1 (hr) Adamantanski derivati aza-krunastih etera i njihova upotreba u terapiji tumora
EP4099988A4 (en) RNA-LOADED NANOPARTICLES AND THEIR USE FOR CANCER TREATMENT
TW200626566A (en) 4, 7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic uses